K. Sari Et Al. , "Ischemia-modified albumin, brain natriuretic peptide, and growth differentiation factor-15 levels in patients with nasal polyps," AURIS NASUS LARYNX , vol.43, no.5, pp.529-536, 2016
Sari, K. Et Al. 2016. Ischemia-modified albumin, brain natriuretic peptide, and growth differentiation factor-15 levels in patients with nasal polyps. AURIS NASUS LARYNX , vol.43, no.5 , 529-536.
Sari, K., Gencer, Z. K., Ede, H., GÖÇMEN, A. Y., & Kantekin, Y., (2016). Ischemia-modified albumin, brain natriuretic peptide, and growth differentiation factor-15 levels in patients with nasal polyps. AURIS NASUS LARYNX , vol.43, no.5, 529-536.
Sari, Kamran Et Al. "Ischemia-modified albumin, brain natriuretic peptide, and growth differentiation factor-15 levels in patients with nasal polyps," AURIS NASUS LARYNX , vol.43, no.5, 529-536, 2016
Sari, Kamran Et Al. "Ischemia-modified albumin, brain natriuretic peptide, and growth differentiation factor-15 levels in patients with nasal polyps." AURIS NASUS LARYNX , vol.43, no.5, pp.529-536, 2016
Sari, K. Et Al. (2016) . "Ischemia-modified albumin, brain natriuretic peptide, and growth differentiation factor-15 levels in patients with nasal polyps." AURIS NASUS LARYNX , vol.43, no.5, pp.529-536.
@article{article, author={Kamran Sari Et Al. }, title={Ischemia-modified albumin, brain natriuretic peptide, and growth differentiation factor-15 levels in patients with nasal polyps}, journal={AURIS NASUS LARYNX}, year=2016, pages={529-536} }